NasdaqCM - Nasdaq Real Time Price USD
Carisma Therapeutics, Inc. (CARM)
0.4516
-0.0966
(-17.62%)
At close: June 13 at 4:00:01 PM EDT
0.4120
-0.04
(-8.77%)
After hours: June 13 at 7:59:45 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-47,559
-59,917
-81,177
-5,116
-37,328
Investing Cash Flow
418
-123
72,408
-32,560
-1,871
Financing Cash Flow
-1,634
344
62,180
33,319
15,962
End Cash Position
7,740
17,909
77,605
24,194
28,551
Interest Paid Supplemental Data
175
192
352
98
--
Capital Expenditure
--
-123
-1,132
-4,660
-1,871
Issuance of Capital Stock
106
2,392
31,237
0
16,328
Issuance of Debt
--
--
0
35,000
--
Repayment of Debt
-414
-1,429
-1,301
-865
--
Free Cash Flow
-47,665
-60,040
-82,309
-9,776
-39,199
12/31/2021 - 2/6/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KLTO Klotho Neurosciences, Inc.
1.6000
-20.00%
NCNA NuCana plc
0.1149
-24.41%
EVGN Evogene Ltd.
1.3800
-9.21%
INSM Insmed Incorporated
98.73
+1.91%
KZIA Kazia Therapeutics Limited
9.30
-5.01%
VXRT Vaxart, Inc.
0.7020
+30.73%
NKTR Nektar Therapeutics
8.59
-1.94%
PHAT Phathom Pharmaceuticals, Inc.
10.64
+6.08%
CTXR Citius Pharmaceuticals, Inc.
0.8746
-4.93%
WINT Windtree Therapeutics, Inc.
0.5920
-1.99%